Immuneering (NASDAQ:IMRX) Azioni, Quote.MetaTitle.unusual-options

Immuneering

Immuneering Corporation - Class A Common Stock

Panoramica

Notizie

Utili

Opzioni

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Comments

Immuneering Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO